Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-ranging study of IV amisulpride (APD421) for prevention of post-operative nausea and vomiting
2011-004267-71Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amisulpride in Nausea and Vomiting (4 arms), sponsored by Acacia Pharma Group Plc. Primary endpoint: Complete response at 24 hours. Started Oct 2011; status: completed.
02
Drugs
amisulpride
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on 2011-004267-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004267-71.